It seems like the answer is now ‘yes’. EndPoints reports: Stealth BioTherapeutics said the FDA would not meet its Tuesday deadline for approving or rejecting the company’s drug, elamipretide. It had been seeking regulatory clearance of elamipretide for a rare disease called Barth syndrome, which affects only about 150 people in the US and causes…
Bain Capital’s buyout of Mitsubishi Tanabe Pharma brings a company with a drug portfolio and pipeline in areas such as immunology, central nervous system disorders, and metabolic disease. This business is the pharmaceuticals division of Japanese conglomerate Mitsubishi Chemical Group. The post Bain Capital Broadens Its Biotech Reach With $3.3B Deal for Mitsubishi Tanabe Pharma…
President-elect Donald Trump’s choice to run the sprawling government agency that administers Medicare, Medicaid, and the Affordable Care Act marketplace — celebrity doctor Mehmet Oz — recently held broad investments in health care, tech, and food companies that would pose significant conflicts of interest. Oz’s holdings, some shared with family, included a stake in UnitedHealth…
[Sponsored] In an interview, Jamie Benton, vice president of HR at Rollins, talked about how he led a shift in the company’s health benefits strategy, producing $29 million in savings over a five-year period. The post Health Plan Transformation: HR Exec Shares How and Why an Employer Changed Its Approach to Healthcare appeared first on…
Medicaid is under threat — again. Republicans, who narrowly control Congress, are pushing proposals that could sharply cut funding to the government health insurance program for poor and disabled Americans, as a way to finance President Donald Trump’s agenda for tax cuts and border security. Democrats, hoping to block the GOP’s plans and preserve Medicaid…
In this brief, we describe Medina v. Planned Parenthood South Atlantic, the Medicaid policies underlying it, and potential implications for Medicaid beneficiaries’ access to reproductive health services.
Blood centers are neutral partners, as they do not compete with hospitals for patients. Instead, they complement hospitals by providing a focused array of high-quality, specialized, patient-centric services, allowing hospitals to maintain primary relationships with patients and their families. The post Blood Centers Complement Hospitals to Drive Cell and Gene Therapy Access appeared first on…
By JEFF GOLDSMITH Healthcare payment in the US has evolved in decades-long sweeps over the past fifty years, as both public programs and employers attempted to contain the rise in health costs. Managed care in the United States has gone through three distinct phases in that time- from physician- and hospital-led HMOs to PPOs and “shadow”…
A small Tennessee hospital that was destroyed by a surging river during Hurricane Helene will soon be rebuilt on low-lying farmland that could face several feet of flooding in a much smaller storm, risking another disaster if the new facility is not built to withstand extreme weather, according to a KFF Health News analysis. Ballad…